Brian Campbell
About Brian Campbell
Brian Campbell serves as the Vice President and Head of Translational Medicine at Prothena Corporation plc. He has extensive experience in the pharmaceutical industry, having held various leadership roles at companies such as Pfizer, Lundbeck Research USA, and MindImmune Therapeutics.
Work at Prothena Corporation
Brian Campbell serves as Vice President and Head of Translational Medicine at Prothena Corporation plc. He has held this position since 2020, contributing to the company's focus on developing therapies for neurodegenerative diseases. His role involves overseeing translational research efforts to bridge the gap between preclinical and clinical development.
Previous Experience in Pharmaceutical Industry
Brian Campbell has extensive experience in the pharmaceutical industry. He worked at Pharmacia as a Post Doctoral Scientist from 2001 to 2003 in Kalamazoo, Michigan. He then joined Pfizer, where he held various roles including Principal Scientist from 2003 to 2006 in Ann Arbor, Michigan, and Senior Principal Scientist from 2006 to 2011 in Groton, Connecticut. He also served as Principal Scientist at Lundbeck Research USA from 2011 to 2014 and as Associate Director, Head of In Vivo Biology from 2014 to 2015.
Role at MindImmune Therapeutics
Brian Campbell co-founded MindImmune Therapeutics, Inc. and served as Vice President of Pharmacology from 2016 to 2018 in Kingston, Rhode Island. In this role, he was involved in advancing the company's pharmacological research and development initiatives.
Education and Expertise in Neuroscience
Brian Campbell earned his Doctor of Philosophy (Ph.D.) in Neuroscience from Wayne State University School of Medicine, studying from 1998 to 2001. His educational background provides a strong foundation for his work in translational medicine and pharmacology.
Current Academic Role
In addition to his industry roles, Brian Campbell has been serving as an Adjunct Ryan Research Professor of Neuroscience at the University of Rhode Island since 2016. He is affiliated with the George & Anne Ryan Institute of Neuroscience, where he contributes to academic research and education in the field.